title: No evidence for a superior platform to develop therapeutic antibodies rapidly in response to MERS-CoV and other emerging viruses.
authors: Protein Interactions Group, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702-12011; dimiter.dimitrov@nih.gov shibojiang@fudan.edu.cn.
authors: Dimiter S
authors: DS
authors: Dimitrov
authors: Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai 20032, China; dimiter.dimitrov@nih.gov shibojiang@fudan.edu.cn.
authors: Shibo
authors: S
authors: Jiang
authors: Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai 20032, China;
authors: Tianlei
authors: T
authors: Ying
authors: Departments of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX 77555;
authors: Chien-Te K
authors: CT
authors: Tseng
authors: Comprehensive AIDS Research Center, Research Center for Public Health, School of Medicine, Tsinghua University, Beijing 100084, China;
authors: Linqi
authors: L
authors: Zhang
authors: State Key Laboratory of Emerging Infectious Diseases, Department of Microbiology, Research Centre of Infection and Immunology, Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong Special Administrative Region of the People's Republic of China.
authors: Kwok-Yung
authors: KY
authors: Yuen
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D057134:Antibodies, Neutralizing / Q000627:therapeutic use*; D018352:Coronavirus Infections / Q000628:therapy*; D006801:Humans; D065207:Middle East Respiratory Syndrome Coronavirus / Q000472:pathogenicity*; D064370:Spike Glycoprotein, Coronavirus / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D064370:Spike Glycoprotein, Coronavirus